Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 17;8:780089. doi: 10.3389/fmolb.2021.780089

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Han, Lei, Chen, Zhang, Huang and Chen.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

IGF2BP2 is an unfavorable prognostic marker in NSCLC. (A) The expression difference of IGF2BP2 in the TCGA database. (B,C) The expression of IGF2BP2 is related to the survival and prognosis of patients with non-small cell lung cancer. (D) The expression difference of IGF2BP2 in non-small cell lung cancer tissues and adjacent tissues (n = 24). (E,F). The expression of IGF2BP2 in non-small cell lung cancer cell lines. Data are presented as mean ± SD. p values are calculated by unpaired two-sided t-test.